|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,202 JPY | +4.11% |
|
+2.04% | +25.83% |
| 2023 | Kakuyasu Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| 2021 | COSMOS Pharmaceutical : Topix closes at near one-month high as investors await earnings | RE |
Kakuyasu Group Co., Ltd. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was JPY 114,960 million. Net income was JPY 609 million.
Basic earnings per share from continuing operations was JPY 65.36. Diluted earnings per share from continuing operations was JPY 63.65.
| 1st Jan change | Capi. | |
|---|---|---|
| +25.83% | 128M | |
| +2.88% | 6.34B | |
| -2.68% | 1.02B | |
| -1.35% | 367M | |
| +0.82% | 211M | |
| -27.22% | 159M | |
| +16.54% | 110M | |
| -11.18% | 66.53M | |
| -28.10% | 50.41M |
KAKUYASU GROUP CO., LTD. 
